Literature DB >> 24490712

Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients.

Kelly E Dunn1, Michael Fingerhood2, Conrad J Wong3, Dace S Svikis4, Paul Nuzzo5, Kenneth Silverman1.   

Abstract

Employment-based reinforcement interventions have been used to promote abstinence from drugs among chronically unemployed injection drug users. The current study used an employment-based reinforcement intervention to promote opioid and cocaine abstinence among opioid and/or cocaine-dependent, HIV-positive participants who had recently completed a brief inpatient detoxification. Participants (n = 46) were randomly assigned to an abstinence and work group that was required to provide negative urine samples in order to enter the workplace and to earn incentives for work (n = 16), a work-only group that was permitted to enter the workplace and to earn incentives independent of drug use (n = 15), and a no-voucher control group that did not receive any incentives for working (n = 15) over a 26-week period. The primary outcome was urinalysis-confirmed opioid, cocaine, and combined opioid/cocaine abstinence. Participants were 78% male and 89% African American. Results showed no significant between-groups differences in urinalysis-verified drug abstinence or HIV risk behaviors during the 6-month intervention. The work-only group had significantly greater workplace attendance, and worked more minutes per day when compared to the no-voucher group. Several features of the study design, including the lack of an induction period, setting the threshold for entering the workplace too high by requiring immediate abstinence from several drugs, and increasing the risk of relapse by providing a brief detoxification that was not supported by any continued pharmacological intervention, likely prevented the workplace from becoming established as a reinforcer that could be used to promote drug abstinence. However, increases in workplace attendance have important implications for adult training programs.

Entities:  

Mesh:

Year:  2014        PMID: 24490712      PMCID: PMC4332775          DOI: 10.1037/a0034863

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  40 in total

Review 1.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults.

Authors:  Mikhail N Koffarnus; Conrad J Wong; Karly Diemer; Mick Needham; Jacqueline Hampton; Michael Fingerhood; Dace S Svikis; George E Bigelow; Kenneth Silverman
Journal:  Alcohol Alcohol       Date:  2011-05-27       Impact factor: 2.826

3.  Associations between duration of illicit drug use and health conditions: results from the 2005-2007 national surveys on drug use and health.

Authors:  Beth Han; Joseph C Gfroerer; James D Colliver
Journal:  Ann Epidemiol       Date:  2010-02-19       Impact factor: 3.797

4.  Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders.

Authors:  Dace S Svikis; Lori Keyser-Marcus; Maxine Stitzer; Traci Rieckmann; Lauretta Safford; Peter Loeb; Tim Allen; Carol Luna-Anderson; Sudie E Back; Judith Cohen; Michael A DeBernardi; Bruce Dillard; Alyssa Forcehimes; William Jaffee; Therese Killeen; Ken Kolodner; Michael Levy; Diane Pallas; Harold I Perl; Jennifer Sharpe Potter; Scott Provost; Karen Reese; Royce R Sampson; Allison Sepulveda; Ned Snead; Conrad J Wong; Joan Zweben
Journal:  Drug Alcohol Depend       Date:  2011-07-29       Impact factor: 4.492

5.  A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes.

Authors:  K Silverman; D Svikis; E Robles; M L Stitzer; G E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2001-02       Impact factor: 3.157

6.  Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.

Authors:  Jeffrey J Everly; Anthony DeFulio; Mikhail N Koffarnus; Jeannie-Marie S Leoutsakos; Wendy D Donlin; Will M Aklin; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Addiction       Date:  2011-05-03       Impact factor: 6.526

7.  Lapse and relapse following inpatient treatment of opiate dependence.

Authors:  B P Smyth; J Barry; E Keenan; K Ducray
Journal:  Ir Med J       Date:  2010-06

8.  Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.

Authors:  Kelly E Dunn; Anthony Defulio; Jeffrey J Everly; Wendy D Donlin; Will M Aklin; Paul A Nuzzo; Jeannie-Marie S Leoutsakos; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Exp Clin Psychopharmacol       Date:  2012-12-03       Impact factor: 3.157

Review 9.  Economic burden of prescription opioid misuse and abuse.

Authors:  Scott A Strassels
Journal:  J Manag Care Pharm       Date:  2009-09

10.  Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.

Authors:  Perrine Roux; M Patrizia Carrieri; Julien Cohen; Isabelle Ravaux; Isabelle Poizot-Martin; Pierre Dellamonica; Bruno Spire
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

View more
  3 in total

Review 1.  Novel interventions to prevent HIV and HCV among persons who inject drugs.

Authors:  Phillip O Coffin; Christopher Rowe; Glenn-Milo Santos
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

2.  Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study.

Authors:  Ayako Yamashita; Shin-Ichi Yoshioka; Yuki Yajima
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-05-04

3.  Comparison of Treatments for Cocaine Use Disorder Among Adults: A Systematic Review and Meta-analysis.

Authors:  Brandon S Bentzley; Summer S Han; Sophie Neuner; Keith Humphreys; Kyle M Kampman; Casey H Halpern
Journal:  JAMA Netw Open       Date:  2021-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.